Welcome Qirui Wang to the NanoProBio Lab

We are pleased to welcome Qirui Wang as a new Ph.D. student (enrolled in 2025) in the NanoProBio Lab at Beihang University. Qirui obtained her Master’s degree from Anhui University of Chinese Medicine, where she developed a strong foundation in biomaterials and nanomedicine. Her current research focuses on designing probiotic/phage–nanozyme composite materials for the treatment of major neurological disorders, including Alzheimer’s disease and stroke.

To date, Qirui has published several research articles as first author or co-first author in internationally recognized journals such as Small Methods and Medical Mycology. Her previous work involves the rational design of probiotic–nanozyme integrated systems and the study of immunomodulatory mechanisms in traditional Chinese medicine, reflecting his strong interdisciplinary background bridging nanotechnology and biomedical science.

Looking ahead, Qirui aims to develop intelligent drug delivery platforms based on bio–nano hybrid systems to advance precision medicine and contribute to innovative therapeutic strategies for complex diseases. We warmly welcome Qirui to the NanoProBio Lab and look forward to her exciting scientific journey with us!